Immuno Oncology Talks
Adoptive therapy with engineered T cell receptors
januar 25, 2023
00:29:32
Speaker(s)
Prof. Reno Debets
In the current, and fifth episode of the “Immuno Oncology Talks”, we discuss adoptive therapy with engineered T cell receptors, with Professor Reno Debets from the Erasmus MC Cancer Institute in the Netherlands. Professor Debets research aims to explore therapeutic strategies by developing and testing adoptive T cell therapy and understand and intervene with the cross-talk between tumor cells and T cells.
For more information please visit:
Sanofi Immuno Oncology Talks website
MAT-BE-2300064 (Ver 1.0) Jan 2023
Also interesting...
MGUS, Science
Risk stratification in patients with monoclonal Gammopathies
Hematology
Cancer cell and gene therapies and the challenges to access the market
Hematology, Hematology
Hemoglobinopathies
Hematology, Hematology, MRD, Multiple Myeloma
Minimal Residual Disease (MRD) – Cost vs Benefit
Hematology